Horizon Therapeutics Plc
US ˙ NASDAQ ˙ US44047T1097
DETTE SYMBOL ER IKKE LÆNGERE AKTIVT

SecurityHZNP / Horizon Therapeutics Plc
InstitutionHealthCor Management, L.P.
Latest Disclosed Ownership0 shares
Latest Disclosed Value $ 0
HealthCor Management, L.P. ownership in HZNP / Horizon Therapeutics Plc

On February 14, 2023 - HealthCor Management, L.P. filed a 13F-HR form disclosing ownership of 0 shares of Horizon Therapeutics Plc (US:HZNP) valued at $0 USD as of December 31, 2022. The entity filed a previous 13F-HR on November 14, 2022 disclosing 229,530 shares of Horizon Therapeutics Plc. This represents a change in shares of -100.00% during the quarter. The current value of the position is $0 USD.

HealthCor Management, L.P. has a history of taking positions in derivatives of the underlying security (HZNP) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

HZNP / Horizon Therapeutics Plc Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2023-02-14 2022-12-31 13F HORIZON THERAPEUTICS PUB L SHS G46188101 0 -229,530 -100.00 0 -100.00
2022-11-14 2022-09-30 13F HORIZON THERAPEUTICS PUB L SHS G46188101 229,530 -674,320 -74.61 14,206 -80.29 1.7767
2022-08-15 2022-06-30 13F HORIZON THERAPEUTICS PUB L SHS G46188101 903,850 193,740 27.28 72,091 -3.51 7.2446
2022-05-16 2022-03-31 13F HORIZON THERAPEUTICS PUB L SHS G46188101 710,110 -122,160 -14.68 74,711 -16.70 4.9838
2022-02-14 2021-12-31 13F HORIZON THERAPEUTICS PUB L SHS G46188101 832,270 -445,958 -34.89 89,685 -35.95 4.8803
2021-11-15 2021-09-30 13F HORIZON THERAPEUTICS PUB L SHS G46188101 1,278,228 43,180 3.50 140,017 21.07 6.0418
2021-08-16 2021-06-30 13F HORIZON THERAPEUTICS PUB L SHS G46188101 1,235,048 -490,602 -28.43 115,650 -27.19 4.6228
2021-05-17 2021-03-31 13F HORIZON THERAPEUTICS PUB L SHS G46188101 1,725,650 -392,440 -18.53 158,829 2.51 5.6194
2021-02-16 2020-12-31 13F HORIZON THERAPEUTICS PUB L SHS G46188101 2,118,090 327,780 18.31 154,938 11.41 5.9750
2020-11-16 2020-09-30 13F HORIZON THERAPEUTICS PUB L SHS G46188101 1,790,310 1,389,270 346.42 139,071 523.92 5.5658
2020-08-14 2020-06-30 13F HORIZON THERAPEUTICS PUB SHS G46188101 401,040 -393,440 -49.52 22,290 -5.28 0.9338
2020-05-15 2020-03-31 13F HORIZON THERAPEUTICS PUB SHS G46188101 794,480 794,480 23,532 1.0058
2020-02-14 2019-12-31 13F HORIZON THERAPEUTICS PUB SHS G46188101 0 -2,628,840 -100.00 0 -100.00
2019-11-14 2019-09-30 13F HORIZON THERAPEUTICS PUB SHS G46188101 2,628,840 -164,830 -5.90 71,583 6.50 2.7058
2019-08-14 2019-06-30 13F HORIZON THERAPEUTICS PUB SHS G46188101 2,793,670 802,341 40.29 67,216 27.71 2.6080
2019-05-15 2019-03-31 13F HORIZON PHARMA SHS G4617B105 1,991,329 1,991,329 52,631 2.1263
2017-02-14 2016-12-31 13F HORIZON PHARMA SHS G4617B105 0 -4,250,000 -100.00 0 -100.00
2016-11-14 2016-09-30 13F HORIZON PHARMA SHS G4617B105 4,250,000 4,250,000 0.00 77,053 4.6950
2015-11-16 2015-09-30 13F HORIZON PHARMA SHS G4617B105 0 -3,200,000 -100.00 0 -100.00
2015-08-14 2015-06-30 13F HORIZON PHARMA SHS G4617B105 3,200,000 -800,000 -20.00 111,168 7.02 5.5972
2015-05-15 2015-03-31 13F HORIZON PHARMA SHS G4617B105 4,000,000 -1,600,000 -28.57 103,880 43.91 4.9561
2015-02-17 2014-12-31 13F HORIZON PHARMA SHS G4617B105 5,600,000 2,025,000 56.64 72,184 64.42 4.0235
2014-11-14 2014-09-30 13F HORIZON PHARMA SHS G4617B105 3,575,000 875,000 32.41 43,901 2.78 2.2544
2014-08-14 2014-06-30 13F HORIZON PHARMA COM 44047T109 2,700,000 2,700,000 42,714 2.1419
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2021-05-17 2021-03-31 13F HORIZON THERAPEUTICS PUB L SHS Call 0 -100.00 0 -100.00 n/a n/a n/a
2021-02-16 2020-12-31 13F HORIZON THERAPEUTICS PUB L SHS Call 400,000 29,260 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.